A phase I trial of BGC 201531 in healthy volunteers.

Trial Profile

A phase I trial of BGC 201531 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 May 2010

At a glance

  • Drugs AP 1531 (Primary)
  • Indications Inflammation; Migraine; Neurogenic pain
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 May 2008 Phase II trial planned to start in the first half of 2009 according to BTG media relase.
    • 02 Apr 2008 Results are expected in the second half of 2008.
    • 02 Apr 2008 Dosing of the second cohort has commenced, according to a BTG media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top